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Vaccinia virus devoid of its E3L gene is sensitive to treatment of RK-13 cells with interferon-a and fails to replicate or
form plaques in HeLa cells. In order to determine function of the E3L gene, vaccinia virus recombinants were constructed
by inserting mutant E3L genes or a gene coding for an alternative dsRNA-binding protein into virus deleted of its wild type
E3L gene. Those viruses that expressed proteins that retained dsRNA binding activity were resistant to the effects of
interferon in RK-13 cells and could replicate in HeLa cells. Recombinant viruses that expressed E3L mutant proteins which
were unable to bind to dsRNA were interferon sensitive in RK-13 cells and could not replicate in HeLa cells. In addition, a
virus that expressed a mutant E3L protein previously characterized as having a low binding affinity for dsRNA exhibited an
intermediate phenotype: it was interferon resistant in RK-13 cells but could not replicate in HeLa cells. This work suggests
that the E3L gene of vaccinia virus functions primarily as a dsRNA-binding protein in allowing resistance to interferon and
in promoting replication in HeLa cells. q 1997 Academic Press
INTRODUCTION the protein product has been characterized (Chang et
al., 1992; Yuwen et al., 1993). The protein contains a
Replication of vaccinia virus (VV) is resistant to pre- dsRNA binding domain (dsRBD) that is found in other
treatment of a number of cells with type-I interferon. The proteins known to bind to dsRNA, such as PKR (Galabru
interferon resistance phenotype of vaccinia virus is asso- and Hovanessian, 1987), the double stranded adenosine
ciated with the E3L gene (Beattie et al., 1995a,b). The deaminase (Kim et al., 1994), human TAR RNA binding
E3L gene encodes two proteins, p25 and p20, both of protein (TRBP) (Park et al., 1994); Xenopus rbpa (Bass et
which bind to double stranded RNA (dsRNA) (Chang et al., 1994); Drosophila melanogaster staufen gene product
al., 1992; Yuwen et al., 1993). E3L inhibits activation of (Ferrandon et al., 1994), the pac1 gene product of the
two interferon-induced, dsRNA-activated enzymes, the fission yeast Schizosaccaromyces pompbe (Rotondo et
protein kinase, PKR, and 2*,5*-oligoadenylate synthetase al., 1995); Escherichia coli RNase III (Court, 1993), and
(Beattie et al., 1995a). Activation of PKR involves auto- group C rotavirus p8 (Langland et al., 1994). For several
phosphorylation and subsequent phosphorylation of sev- proteins, including the E3L gene products, the dsRBD
eral substrates, including the a subunit of eukaryotic has been shown to be sufficient for binding to dsRNA.
protein synthesis initiation factor 2 (eIF-2) (Samuel, 1979). In fact, the group C rotavirus p8 protein, at 69 amino
These events lead to a block in protein synthesis initia- acids, consists of little more than a dsRBD (Langland et
tion, and therefore to impairment of translation. Activation al., 1994).
of 2*,5*-oligoadenylate synthetase leads to synthesis of Vaccinia virus deleted of the E3L gene, VVDE3L, is
short 2*,5*-linked oligomers of ATP (Kerr and Brown, interferon sensitive in RK-13 cells (Chang et al., 1995)
1978) that can activate a constitutive RNase, RNase L, and mouse L929 cells (Beattie et al., 1995a) and has
which can degrade both viral and cellular RNAs (Floyd- a restricted host range phenotype (Chang et al., 1995).
Smith et al., 1981). VVDE3L can have its host range restored by transient
Inhibition of PKR and 2*,5*-oligoadenylate synthetase
transfection of plasmids which supply the wt E3L product
is thought to be due to the dsRNA binding activity of the
in trans (Chang et al., 1995). Plasmids which code for
E3L products. The E3L gene has been sequenced and
mutants of E3L that do not bind dsRNA fail to rescue
replication of VVDE3L (Chang et al., 1995), suggesting
that the E3L gene products function to promote replica-1 Current address: Department of Biology and Microbiology, Univer-
sity of Wisconsin Oshkosh, 800 Algoma Boulevard, Oshkosh, WI 54901- tion in a wide variety of host cells by binding to and
8640. sequestering dsRNA. The restricted host range and inter-
2 To whom correspondence and reprint requests should be ad- feron sensitivity of E3L deletion mutants can also be atdressed at Department of Microbiology and the Molecular and Cellular
least partially rescued in trans by the reovirus s3 proteinBiology Graduate Degree Program, Arizona State University, Tempe,
AZ 85287-2701. Fax: 1 (602) 965-0098. E-mail: bjacobs@asu.edu. (Beattie et al., 1995a), which has been shown to bind to
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dsRNA (Huismans and Joklik, 1976). Since s3 has little Jacobs, 1993). The D83N E3L mutant was subcloned into
pBSIIKS/. This was done by cleaving pGEM-5T/D83Namino acid sequence similarity to the E3L products,
these results again argue that the mechanism of action (Chang and Jacobs, 1993) with EcoRI and inserting it
into previously EcoRI cut pBSIIKS/. The D83N E3L wasof E3L is through its dsRNA binding activity.
The transient transfection results have demonstrated determined to be in the T7 orientation in pBSIIKS/. Next,
the D83N E3L gene was removed from the pBSIIKS/a correlation between ability of the E3L product to bind
to dsRNA and unrestricted host range phenotype (Chang vector via HincII and BamHI digestion and subcloned
into pMPE3LDGPT 748 that had been previously cut withet al., 1995). However, the ability of E3L mutant proteins
to rescue the interferon sensitivity of VVDE3L cannot be PstI, treated with T4 DNA polymerase and cleaved with
BamHI. Inserted D83N was confirmed via HindIII/BamHIshown in trans. Interferon sensitivity of VVDE3L cannot
be tested in HeLa cells, which are easily transfected at digestion.
The D37N mutation was created by PCR of pBS-E3Lhigh efficiency, because this virus does not replicate in
HeLa cells (Chang et al., 1995). VVDE3L can replicate with the following oligonucleotides: 5*-AGGCCTGCA-
GATGGAGAAGCGAGAAGTT-3* (initiator codon under-in RK-13 cells (Chang et al., 1995), but these cells have
a very low transfection frequency, which prevents detect- lined) and 5*-TCGCGAATTCTCAGAATCTAATGATGAC-
3*. The PCR product was cleaved with PstI and EcoRIable rescue of virus deleted for E3L from the effects of
IFN treatment. In this report, various mutant E3L genes and cloned into pBSIIKS/. The altered gene was then
subcloned into pMPE3LDGPT 748. The pBSIIKS//D37Nwere recombined into VVDE3L. Those resultant viruses
which expressed functional dsRNA binding proteins construct was cleaved with HincII and a phosphorylated
BamHI linker was inserted into the HincII site. Subse-were resistant to the effects of interferon in RK-13 cells
and could replicate in HeLa cells. Recombinant viruses quently, the construct containing the linker (pBSIIKS//
D37N) and pMPE3LDGPT 748 were cleaved with BamHI,that expressed E3L mutant proteins which were unable
to bind to dsRNA were interferon sensitive in RK-13 cells and the E3L mutant gene was inserted into the BamHI
site of pMPE3LDGPT 748. Orientation of the E3L genesand could not replicate in HeLa cells. Thus, confirming
the results of the transient transfections, a correlation was determined by PstI digestion.
Construction of VVE3LD7C, VVE3LD26C, VVE3LG164V,exists between the viral expression of a dsRNA binding
protein and the viral host range phenotype. This correla- VVDE3L/p8, and VVDE3L/S4 has been previously de-
scribed (Kibler et al., 1997). The E3L gene was recon-tion is extended here to include restoration of interferon
resistance. structed into VVDE3L after subcloning the E3L coding
region from pBS-E3L into pMPE3LDGPTMCS using
BamHI and HindIII.MATERIALS AND METHODS
In vivo recombination of genes into VVDE3LCells and viruses
Insertion of genes into VVDE3L, selection of recombi-HeLa cells were maintained as monolayers in Eagle’s
nants, and growth of virus stocks was performed as pre-minimum essential medium (MEM) supplemented with
viously described, using either CaPO4 precipitation (Baier50 mg/ml gentamicin sulfate and 5% fetal bovine serum
et al., 1993) or lipofection (Kibler et al., 1997) to transfect(Hyclone). RK-13 cells were obtained from the American
DNA into cells. Briefly, cells infected with VVDE3L (whichType Culture Collection (Rockville, MD). Cells were main-
contains a lacZ gene in the E3L locus) were transfectedtained in MEM supplemented with 11 nonessential
with the indicated plasmid. After a single cycle of replica-amino acids (GIBCO), 50 mg/ml gentamicin sulfate, and
tion, released virus was plated onto RK-13 cells in the5% fetal bovine serum (Hyclone). All cell lines were main-
presence of mycophenolic acid to select for viruses thattained in a 377, 5% CO2 environment.
had incorporated the plasmid through a single recombi-Vaccinia virus VC-2 (Copenhagen strain), designated
nation event. After several rounds of plaque purificationin this paper as wtVV, was the parent for all viruses used
in the presence of mycophenolic acid, viruses werein this study.
plated in the absence of mycophenolic acid to allow reso-
lution of plasmid sequences by homologous recombina-Plasmid constructs for in vivo recombination
tion. Viruses which had incorporated the desired gene
in place of lacZ were identified as forming clear plaquesThe pMPE3LDGPT 748 recombination vector was
kindly supplied by James Tartaglia (Virogenetics). This after staining with X-gal. Constructs were verified by PCR
analysis for deletion mutants and by sequencing for pointplasmid contains left and right E3L flanking regions, in-
cluding the E3L promoter, adjacent to the E. coli gpt mutants.
gene, which codes for resistence to mycophenolic acid.
IFN sensitivity/plaque reduction assaysAll variants of the E3L gene reconstructed into VVDE3L
were from VV, WR strain. The D83N mutant of E3L was RK-13 cells (seeded in six-well, 10 cm2/well dishes)
were pretreated for 24 h with 0, 0.1, 1.0, 10, 100, andoriginally constructed by Hwai-Wen Chang (Chang and
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1000 Units/ml of rabbit interferon (Lee Biomolecular).
Each well of cells was then infected with 0.1 ml of MEM
containing 2% FCS and containing 50-100 PFUs and the
virus was adsorbed for 1 h and overlaid with liquid me-
dium. The infected cells were incubated for 48 h at 377.
Plaques were visualized by aspirating the medium and
staining the monolayers with 0.1% crystal violet in 20%
ethanol for 5 min at room temperature (Earl and Moss,
1991). All assays were repeated a minimum of three
times.
Single step growth curve of recombinant viruses
Confluent monolayers of rabbit RK-13 cells were either
treated with 200 U/ml of rabbit interferon-a for 22 h or
were mock-treated. Cells were infected with various re-
combinants of VV at an m.o.i. of 1. Infected cells were
harvested at 1, 6, 12, 18, and 24 or 30 h postinfection.
Each time point was titered via standard plaque assays
on monolayers of RK-13 cells and stained with crystal
violet as described above.
RESULTS
The VV E3L gene is necessary for interferon resistance
(Beattie et al., 1995a,b) and to allow replication in a wide
range of host cells, including HeLa cells (Chang et al.,
1995). In order to better define the function of the E3L
FIG. 1. Schematic summary of the dsRNA binding activity of thegene we have replaced the wt E3L gene with genes
various proteins whose genes have been inserted into the E3L locuscoding for various mutants of E3L or with a gene coding
of VVDE3L. The numbers indicate the amino acid residue within thefor the porcine group C NSP3 p8 protein. Porcine p8 is
protein. Boxes indicate the conserved dsRNA binding motif. (A) Mutants
the smallest known natural dsRNA-binding protein and of E3L. (B) The group C rotavirus NSP3 gene.
is thought to consist of little more than a dsRBD (Lang-
land et al., 1994). Mutants of E3L included proteins that
bind to dsRNA with wt affinity but which are altered in with up to 1000 U/ml. The VVE3LD7C recombinant virus
localization within the cell (VVE3LD83N; see Fig. 1A; was also fully interferon resistant. Previous characteriza-
Chang and Jacobs, 1993; Chang et al., 1995), proteins tion of the D7C gene in the transient-transfection assay
that bind to dsRNA with wt affinity and localize normally showed that it rescued VVDE3L protein synthesis and
within the cell (VVE3LD37N; data not shown), proteins replication poorly in HeLa cells (Chang et al., 1995), pre-
with decreased affinity for dsRNA (VVE3LD7C; Chang sumably due to its reduced affinity to bind dsRNA (Chang
and Jacobs, 1993), and proteins which fail to bind to and Jacobs, 1993). Virus containing the porcine group C
dsRNA (VVE3LD26C and VVE3LG164V; Chang and Ja- rotavirus p8 gene had intermediate sensitivity to inter-
cobs, 1993). In addition, as a control, we have inserted feron when measured by a plaque reduction assay.
the full-length WR strain E3L gene into virus deleted for Plaque formation by VVDE3L/p8 was reduced 60–80%
E3L (VVrE3L). in cells treated with 100–1000 U/ml of interferon. Those
viruses which contained E3L genes that were altered
IFN sensitivity assays on vaccinia recombinants within the dsRNA binding domain rendering them unable
to bind to dsRNA, VVE3LG164V and VVE3LD26 C, yielded
To determine if mutants of the E3L gene could amelio- results comparable to VVDE3L.
rate the IFN sensitive phenotype of VVDE3L, plaque re-
duction assays were performed in RK-13 cells as de- Restoration of host range phenotype by vaccinia
scribed under Materials and Methods. Results are shown recombinants
in Fig. 2. Plaque formation by wtVV, as well as by recom-
binants that contained mutant E3L genes encoding func- Vaccinia virus deleted of its E3L gene cannot form
plaques in HeLa cells (Chang et al., 1995). We wantedtional dsRNA binding proteins in which the binding do-
main has not been altered (VVrE3L, VVE3LD37N, and to determine which mutants of E3L would restore plaque
formation in HeLa cells. Therefore, HeLa cells were in-VVE3LD83N) were resistant to interferon pretreatment
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FIG. 2. Plaque reduction assays to determine interferon sensitivity of vaccinia virus recombinants were performed in RK-13 cells as described
under Materials and Methods. The data are shown as percentage of the maximum number of plaques for each virus.
fected with the recombinant viruses and efficiency of since VVE3LD7C was fully resistant to interferon treat-
ment of RK-13 cells (Fig. 2) and since transient expres-plaquing in HeLa cells was analyzed relative to plaquing
in RK-13 cells (Table 1). wtVV, VVrE3L, VVE3LD37N, and sion of D7C partially rescued replication of VVDE3L
(Chang et al., 1995).VVDE3L/p8 were able to plaque in HeLa cells with the
EOP ranging from 0.1 to 2.0. No plaques were observed
with VVDE3L, VVE3LG164V, or VVE3LD26C. These re- Single step growth curve of vaccinia recombinants
sults correlate with the dsRNA binding phenotype. In
Single step growth curves were performed in HeLaaddition, VVE3LD7C had an EOP of 1.3 1 1005 and did
cells (Fig. 4) or in RK-13 cells in the absence or pretreat-not plaque in HeLa cells. This was somewhat surprising
ment of interferon (Fig. 3). All viruses were able to repli-
cate with titers ranging from 2 1 107 PFU/ml to 1 1 108
TABLE 1
PFU/ml in untreated RK-13 cells (Figs. 3A and 3C). In
Efficiency of Plaquing HeLa Cells RK-13 cells pretreated with interferon, titers of VVDE3L,
VVE3LG164V, and VVE3LD26C were reduced 200-fold
Virus RK-13 HeLa EOP
as compared to wtVV (Figs. 3B and 3C). Again, replication
in the presence of interferon correlated with the dsRNAwtVV 3.15 1 109 9.4 1 108 0.45
VVDE3L 2.60 1 108 1.00 1 103 1.30 1 1006 binding phenotype. wtVV, VVrE3L, VVE3LD83N, VVE3L-
VVE3LD37N 3.50 1 108 7.05 1 108 2.00 D37N, and VVE3LD7C replication was fully resistant to
VVE3LD83N 3.00 1 108 5.50 1 107 0.39 treatment with interferon, in agreement with the results of
VVE3LG164V 1.70 1 107 1.00 1 103 5.60 1 1005
plaque reduction assays (Fig. 2). Somewhat surprisingly,VVE3LD7C 7.70 1 107 1.00 1 103 1.30 1 1005
replication of VVDE3L/p8 under single cycle conditionsVVE3LD26C 2.00 1 107 1.00 1 103 5.00 1 1005
VVDE3L/p8 2.90 1 108 5.90 1 107 0.18 was completely resistant to pretreatment with interferon
VVrE3L 4.10 1 108 1.80 1 108 0.44 (Fig. 3C), in contrast to results from plaque reduction
assays (Fig. 2).
Note. Representative results of virus stocks titered in RK-13 or HeLa
Replication in HeLa cells under single cycle conditionscells. The data are shown as mean plaque forming units per milliliter
gave results similar to those obtained under plaque(PFU/ml). The relative efficiency of plaquing (HeLa/RK-13, EOP) is also
shown. assay conditions. Those viruses that did not express
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FIG. 3. Single step growth curves of recombinant viruses in RK-13 cells with (B and C as indicated) or without interferon (A and C as indicated)
pretreatment. Cells were infected with an m.o.i. of 1 and each time point was titered in RK-13 cells via standard plaque assays and stained via
crystal violet. (A and B) Viruses were harvested at 1, 6, 12, 18, and 24 h postinfection. (C) Viruses were harvested at 30 h postinfection.
functional dsRNA binding proteins, VVDE3L, VVE3- DISCUSSION
LG164V, and VVE3LD26C, did not replicate in HeLa cells
In this report, we demonstrate that products of the(Figs. 4A and 4B). wtVV, VVrE3L, VVE3LD83N, and
VV E3L gene which contain a functional dsRNA bindingVVE3LD37N yielded similar titers of 2–5 1 108 PFU/ml
domain are necessary to mediate the interferon resis-in HeLa cells (Figs. 4A and 4B). Yields of VVDE3L/p8
tance phenotype of vaccinia virus and for replication ofwere routinely two- to threefold lower than wtVV in both
HeLa cells (Fig. 4B) and in RK-13 cells (Fig. 3C). vaccinia virus in HeLa cells. We recombined several mu-
AID VY 8881 / 6a54$$$223 12-15-97 10:28:08 vira AP: VY
274 SHORS ET AL.
FIG. 4. Single step growth curves of recombinant viruses in HeLa cells. Cells were infected with an m.o.i. of 1 and each time point was titered
in RK-13 cells via standard plaque assays and stained via crystal violet. In A, viruses were harvested at 1, 6, 12, 18, and 24 h postinfection. In B,
viruses were harvested at 1 and 24 h postinfection.
tants of the E3L gene into a virus deleted of its E3L gene, virus (Shchelkunov et al., 1993) and ectromelia virus (M.
Buller, pers. commun.). A 25-kDa protein that cross-re-which is interferon sensitive and unable to replicate in
HeLa cells. We were then able to ask which recombinant acted with anti-E3L serum was also detected in cowpox-
and rabbitpox-infected cells (unpublished observations).viruses were resistant to the effects of interferon. Recom-
binants containing an E3L gene with deletions of 37 or Perhaps the N-terminus of E3L is important for replication
in whole animals or for replication under different condi-83 amino acids from its N terminus were interferon resis-
tant and able to replicate in HeLa cells. These mutations tions than those described in this paper. Virus containing
D83N does induce apoptosis in infected cells, but onlyhave no affect on dsRNA binding activity or PKR inhibition
(Chang and Jacobs, 1993). Thus, to the limit of the assays at very late times (36 h) postinfection (unpublished obser-
vations).described in this paper, the N-terminal 44% of the E3L
gene is completely dispensible for interferon resistance Virus containing D7C, which binds to dsRNA with low
affinity (Chang and Jacobs, 1993), had an intermediateand to promote replication in HeLa cells. Since the pro-
tein encoded by this gene does not migrate to the nu- phenotype. VVE3LD7C was fully resistant to treatment
of RK-13 cells with interferon, but failed to replicate evencleus of transfected (Chang et al., 1995) or infected cells
(unpublished observations), these results suggest that in untreated HeLa cells. This intermediate phenotype is
consistent with what is known about D7C protein andnuclear localization is unimportant for these phenotypes.
This result is somewhat surprising in that the N-terminus about HeLa cells and RK-13 cells. HeLa cells contain
constitutively high levels of activatable PKR. RK-13 cellsof E3L is well conserved between vaccinia virus, variola
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